Current Assets
Net Cash Collateral Received - Derivative Instruments
Medtronic Net Cash Collateral Received - Derivative Instruments decreased by 53.9% to $125M in Q1 2025 compared to the prior quarter. Over 2 years (FY 2021 to FY 2024), Net Cash Collateral Received - Derivative Instruments shows an upward trend with a 375.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ1 2015
Last reportedQ1 2025Feb 24, 2026
Metric ID:
net_cash_collateral_received_derivativesHistorical Data
13 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $12M | $0 | $0 | $1M | $6M | $0 | $29M | $92M | $52M | $271M | $125M |
| QoQ Change | — | — | — | -100.0% | — | — | +500.0% | -100.0% | — | +217.2% | -43.5% | +421.2% | -53.9% |
| YoY Change | — | — | — | — | — | — | — | -100.0% | — | >999% | — | +834.5% | — |
Range$0 – $271M
Avg YoY Growth+722.6%
Median YoY Growth+834.5%
Net Cash Collateral Received - Derivative Instruments at Other Companies
Frequently Asked Questions
- What is Medtronic's net cash collateral received - derivative instruments?
- Medtronic (MDT) reported net cash collateral received - derivative instruments of $125M in Q1 2025.
- What is the long-term trend for Medtronic's net cash collateral received - derivative instruments?
- Over 2 years (2021 to 2024), Medtronic's net cash collateral received - derivative instruments has grown at a 375.2% compound annual growth rate (CAGR), from $12M to $271M.